(Q83292729)

English

Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

scientific article published on 01 February 2009

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Richard E Pratley

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

publication date

1 February 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

published in

Expert Opinion on Pharmacotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

page(s)

503-512

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Identifiers

DOI

10.1517/14656560802694713

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

PubMed publication ID

19191685

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19191685

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19191685%20AND%20SRC:MED&resulttype=core&format=json

(Q83292729)

Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)